Navigation Links
Seibel II IntraLase Flap Lifter & Retreatment Spatula, Titanium

ProductsSeibel II IntraLase Flap Lifter & Retreatment Spatula, Titanium
Company Rhein Medical, Inc.
Item Seibel II IntraLase Flap Lifter & Retreatment Spatula, Titanium
Features 
Description Unique In-Line Footplates Are Turned 90 Degrees To Allow Full Visualization Of The Diamond Blade While Incising Tissue. Special Mirror-Polished Double Footplate Construction Insures Precise Blade Depth Penetration. Pre-Set Blade Extension Settings Of 0.5mm, 0.55mm, 0.6mm, Including Full Retraction And Full Extension. 1mm Wide Snub Nose Diamond Blade Is Ideal For Making The Paracentesis Incision. All Components Are Made Of Titanium, Including The Spring. Reusable, Autoclaveable, Made In The USA, & Available For A Surgical Evaluation Without Obligation.
Info Rhein Medical, Inc.
Customer Service: (800) 637-4346
Web site: http://www.rheinmedical.com

Related medicine products :

1. Osher-Seibel Folding Forceps
2. Seibel LRI Diamond Knife
3. Seibel 3-D Lid Speculum
4. IntraLase FS Femtosecond Laser
5. Gulani Edge Delineator/Lifter
6. LASIK Retreatment Forceps
7. Hydroview Insertion Forceps - Titanium
8. Titanium Bayonet Forceps
9. Titanium Foot Activated Forceps
10. Craniofix Titanium Clamp
11. Craniofix Titanium Burr Hole Clamp
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products:
(Date:5/15/2008)..., In the wake of divorce, illness, violence and o...oung children are liable to experience temporary s... their knapsack for kindergarten. Published in th...community-wide study from Rochester, New York, war...ng difficulties and that these separations are goo...
(Date:5/15/2008)... INDIANAPOLIS, May 15 /PRNewswire-FirstCall/ -... into treatment decisions may fare better as a,res...ll lung cancer (NSCLC),clinical trial. Data from t...LIMTA(R) (pemetrexed for injection), will be prese...ciety of Clinical Oncology (ASCO) in Chicago,Ill....
(Date:5/15/2008)..., Washington, DC -- With the goal of tailoring ca... Georgetown University Medical Center today presen...p doctors more reliably assess treatment efficacy ... can take several weeks and sometimes months to de...g because it can take that long to observe any sig...
(Date:5/15/2008)..., , HOUSTON - Celecoxib, the anti-inflammato...x, has proven to be safe and reduces a specific pr... the lung, according to a study from The Universit...ing demonstrates the significance of COX-2 inhibit...t higher risk of developing the disease. , The s...
Breaking Medicine News(10 mins):Health News:Separation from mom, dad linked with learning trouble in kids 2Health News:Separation from mom, dad linked with learning trouble in kids 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 2Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 4Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 5Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 6Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 7Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3
...ists and dental hygienists as lifesavers, but Dr. ...sistant professor of dental// hygiene at New York ...ion to routinely conduct periodontal evaluations a...gs as well as how to recognize the clinical signs ...
...stem cells from the lungs of transplant patients d...or cells //reside in adult organs and are not deri...ty that the cells may be able to help with the rej...ous kinds of lung disease. The study by Universit...
...ion and the Medicines for Malaria Venture plan to ...he United Arab Emirates (UAE). The center will foc...gs, Gulf News reports. Gates Foundation and MMV r...fficials from the UAE Ministry of Health to discus...
...o the parents of Canada’s conjoined twins and to t...ors have confirmed //after days of several tests t...onjoined twins, known by the names Krista and Tati...ir heads joined. The twins, who are four months of...
Other Medicine News:Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 2Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 3Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 4Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 2Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 3
(Date:5/15/2008)...y for Population Most Affected by Disease -, WAYN...-FirstCall/ --,Bayer HealthCare Pharmaceuticals, I...) today announced that Nexavar(R) (sorafenib) tabl...3 percent (HR=0.68;,p-value=0.014) in patients in ...ar carcinoma (HCC), or primary liver cancer versus...
(Date:5/15/2008)...swire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MDV...e 1-2 clinical,trial of its novel androgen recepto...l presentation at the 44th American Society of Cli... Session title: New Targeted Strategies for Pati...Monday, June 2 at 11:30 a.m. Central Time Abstrac...
(Date:5/15/2008)...O Showed Acceptable Tolerability Profile, ..., WOODCLIFF LAKE, N.J., May 15 /- Th...mesylate (E7389) demonstrated activity in a,heavil...nced or metastatic,breast cancer, according to res...e study also suggests that eribulin mesylate has a...
(Date:5/15/2008)...Newswire-FirstCall/ -- Schering-Plough,Corporation...and treatment of,chronic hepatitis C virus (HCV) i...linical studies with PEGINTRON(TM) (peginterferon ...on therapy, as well as boceprevir, the,company,s i...e presented at,the 39th annual Digestive Disease W...
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Revise guidelines for weight gain during pregnancy says Saint Louis U obstetrician 14070 1Revise guidelines for weight gain during pregnancy says Saint Louis U obstetrician 14070 2Hospital Chain and Hand Picked Union SEIU Forced to Cancel Rigged Election After Protests by RNs and Other Employees 14065 1Hospital Chain and Hand Picked Union SEIU Forced to Cancel Rigged Election After Protests by RNs and Other Employees 14065 2Health Plan and Preferred Provider Network Communities Issue Joint Statement on Passage of Healthcare Simplification Act 14062 1Health Plan and Preferred Provider Network Communities Issue Joint Statement on Passage of Healthcare Simplification Act 14062 2Ambulatory Services of America Inc Announces Joint Venture with Southern Ocean County Radiation Oncology LLC 14058 1Ambulatory Services of America Inc Announces Joint Venture with Southern Ocean County Radiation Oncology LLC 14058 2
...PRNewswire-FirstCall/ --,Replidyne, Inc. announced... trial using faropenem medoxomil (faropenem) in pe...common infection of the,middle ear. Initial analys...ry objective to show that faropenem was effective ...o permit the dose,selection for Phase III trials i...
...RNewswire-FirstCall/ --,Advanced Magnetics today a...multi- center clinical studies of ferumoxytol as a... presented during,the National Kidney Foundation (...ril 10th through 14th in Orlando, Florida. Two,pos...nted on,Wednesday, April 11, 2007 at approximately...
Other Medicine Technology:Replidyne Phase II Pediatric Trial Meets Primary Objective 2Replidyne Phase II Pediatric Trial Meets Primary Objective 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4